PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
12-Aug-2020 FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting FibroGenesis
12-Aug-2020 Advent Life Sciences announces sale of its portfolio Company KaNDy Therapeutics to Bayer AG for USD 425M upfront plus USD 450M in potential development milestones followed by further potential commercial milestones Advent Life Sciences
12-Aug-2020 Santhera Completes Capital Increase for Financing Arrangements Santhera Pharmaceuticals
12-Aug-2020 Newron Pharmaceuticals provides clinical and business update Newron Pharmaceuticals
12-Aug-2020 Pre-Close Trading Statement Sareum Holdings PLC
12-Aug-2020 Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication Saillant Therapeutics
12-Aug-2020 Santhera Completes Capital Increase for Financing Arrangements Santhera Pharmaceuticals
12-Aug-2020 Abeona Therapeutics Reports Second Quarter Financial Results and Business Updates Abeona Therapeutics
10-Aug-2020 Up and Running: Corona-proof Business Development Partnering RauCon GmbH & Co KG
10-Aug-2020 How COVID-19 changed the way patients responded to a heart attack University of Leeds
10-Aug-2020 Biophytis Receives Approval from Brazilian Health Regulatory Agency to Start COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patients with COVID-19 Related Respiratory Failure Biophytis SA
10-Aug-2020 Lilly Initiates Phase 3 Trial of LY-CoV555 for Prevention of COVID-19 at Long-Term Care Facilities in Partnership with the National Institute of Allergy and Infectious Diseases (NIAID) Eli Lilly and Company
10-Aug-2020 Wockhardt announces COVID-19 vaccine partnership with UK Government Wockhardt
10-Aug-2020 BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China BioNTech SE
10-Aug-2020 Joint working between PCNs and mental health providers must accelerate in the aftermath of COVID-19 PCN Network
10-Aug-2020 CIMZIA® is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum UCB
10-Aug-2020 Lundbeck discontinues phase II proof of concept study of Lu AF11167 in patients with negative symptoms of schizophrenia H. Lundbeck A/S
10-Aug-2020 Fujifilm Selects Kinaxis RapidResponse for Agility in its Medical System Supply Chain Kinaxis Inc
10-Aug-2020 Thermo Fisher Scientific Launches Exclusive Website for its Chemical Business Offerings in India Thermo Fisher Scientific
10-Aug-2020 Clovis Oncology Announces First Patient Enrolled in the Phase 2 Portion of the LIO-1 Trial Evaluating the Combination of Lucitanib and Opdivo in Gynecologic Cancers Clovis Oncology, Inc